The microbiome is central to human health, and early-life gut microbiota has a profound implication on shaping our immune system, especially at the prenatal or neonatal stages.
Since the discovery of the microbiome, many scientists have questioned both the mother-to-infant bacterial transmission process and microbiome evolution during the very first years of our lives.
Is the prenatal or the postnatal period the most critical phase for the development of microbiota composition?
The interaction between cancer and bacteria is not new.
As early as 1868, Busch began infecting sarcoma patients with erysipelas. This experiment was a semi-success in sofar as the reduction of the tumors was quickly followed by a reappearance of the cancer. In 1891, Coley pursued Busch's work and injected a throat cancer patient with Streptococcus erysipelas cultures: this time, the patient returned to a healthy condition for eight years.
“Huge opportunities”. “Many hurdles”. “Enormous potential”.
It's just an excerpt of the several terms you'll come across if you search for them on the web.
What am I talking about?
Exosomes. Also referred to as Prostasomes, Tolerosomes, Dexosomes, or Nanovesicles.
Markers of cancer diseases, the basis of broad diagnostic platform, and potential future therapeutics, exosomes have now surpassed 2,000 annual scientific publications.
But why are exosomes so unique?
Not a week goes by without a scientific article dealing with the microbiota. And we often hear that understanding the microbiota is explaining our illnesses. But what is exactly the microbiota and how does it influence our condition?
An introduction to our inner forest or what is more commonly called our second brain...